Literature DB >> 11840339

Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.

Ana Ramírez de Molina1, Verónica Penalva, Luisa Lucas, Juan Carlos Lacal.   

Abstract

Ras proteins are molecular switches that control signaling pathways critical in the onset of a variety of human cancers. The signaling pathways activated by Ras proteins are those controlled by its direct effectors such as the serine-threonine protein kinase Raf-1, the exchange factor for other GTPases Ral-GDS, and the lipid kinase PI3K. As a consequence of Ras activation, a number of additional enzymes are affected, including several members of the serine-threonine intracellular proteins kinases as well as enzymes related to phospholipid metabolism regulation such as phospholipases A2 and D, and choline kinase. The precise mechanisms by which ras oncogenes impinge into these later molecules and their relevance to the onset of the carcinogenic process is still not fully understood. Here we have investigated the mechanism of regulation of choline kinase by Ras proteins and found no direct link between PLD and choline kinase activation. We provide evidence that Ras proteins regulate the activity of choline kinase through its direct effectors Ral-GDS and PI3K, while the Raf pathways seems to be not relevant in this process. The importance of Ras-dependent activation of choline kinase is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840339     DOI: 10.1038/sj.onc.1205144

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.

Authors:  Maria D Cao; Mailin Döpkens; Balaji Krishnamachary; Farhad Vesuna; Mayur M Gadiya; Per E Lønning; Zaver M Bhujwalla; Ingrid S Gribbestad; Kristine Glunde
Journal:  NMR Biomed       Date:  2012-01-26       Impact factor: 4.044

2.  Elucidation of human choline kinase crystal structures in complex with the products ADP or phosphocholine.

Authors:  Enrico Malito; Nikolina Sekulic; Wei Cun See Too; Manfred Konrad; Arnon Lavie
Journal:  J Mol Biol       Date:  2006-09-03       Impact factor: 5.469

Review 3.  Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.

Authors:  Siver Andreas Moestue; Olav Engebraaten; Ingrid Susann Gribbestad
Journal:  Mol Oncol       Date:  2011-04-23       Impact factor: 6.603

4.  Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.

Authors:  Sarah Marie Schwarzenböck; Philipp Schmeja; Jens Kurth; Michael Souvatzoglou; Roman Nawroth; Uwe Treiber; Guenther Kundt; Sandra Berndt; Keith Graham; Reingard Senekowitsch-Schmidtke; Markus Schwaiger; Sibylle I Ziegler; Ludger Dinkelborg; Hans-Jürgen Wester; Bernd Joachim Krause
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

5.  Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.

Authors:  Sean P Arlauckas; Anatoliy V Popov; Edward J Delikatny
Journal:  Mol Cancer Ther       Date:  2014-07-15       Impact factor: 6.261

6.  Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their malignant counterparts.

Authors:  Hanna M Romanska; Stefano Tiziani; Rachael C Howe; Ulrich L Günther; Zulfiqar Gulzar; El-Nasir Lalani
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

7.  A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas.

Authors:  E Hernando; J Sarmentero-Estrada; T Koppie; C Belda-Iniesta; V Ramírez de Molina; P Cejas; C Ozu; C Le; J J Sánchez; M González-Barón; J Koutcher; C Cordón-Cardó; B H Bochner; J C Lacal; A Ramírez de Molina
Journal:  Oncogene       Date:  2009-05-18       Impact factor: 9.867

8.  Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment.

Authors:  Sebastian A Müller; Korbinian Holzapfel; Christof Seidl; Uwe Treiber; Bernd J Krause; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-08       Impact factor: 9.236

9.  Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.

Authors:  David Gallego-Ortega; Ana Ramirez de Molina; Maria Angeles Ramos; Fatima Valdes-Mora; Maria Gonzalez Barderas; Jacinto Sarmentero-Estrada; Juan Carlos Lacal
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

Review 10.  Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy.

Authors:  M Beloueche-Babari; Y-L Chung; N M S Al-Saffar; M Falck-Miniotis; M O Leach
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.